IQVIA Holdings Inc - Company Profile
Powered by
All the data and insights you need on IQVIA Holdings Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date IQVIA Holdings Inc Strategy Report
- Understand IQVIA Holdings Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on IQVIA Holdings Inc’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
---|---|---|---|---|
05 May 2022 | TikoMed Enters into Agreement with IQVIA | Partnership | - |
TikoMed AB
IQVIA Holdings Inc |
25 Aug 2021 | IQVIA Acquires DAVASO Group Holding | Acquisition |
IQVIA Inc
|
DAVASO Group Holding GmbH
|
05 Aug 2021 | NRX Pharmaceuticals Inc Enters Phase II/III Clinical Trial Agreement with IQVIA Holdings Inc for IIBR-100 (GDCT0426551) | Contract Service Agreement |
NRX Pharmaceuticals Inc
|
IQVIA Holdings Inc |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer